SCHEMBL6364611

SCHEMBL6364611

COC(=O)C=Cc1cc2ccccc2n1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALB P02768 1/20 0.47
KMT2A Q03164 2/20 0.47
KDM4E B2RXH2 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
MCL1 Q07820 1/20 0.46
GRIN2D O15399 1/20 0.45
GRIN3B O60391 1/20 0.45
GRIN1 Q05586 1/20 0.45
GRIN2A Q12879 1/20 0.45
GRIN2B Q13224 1/20 0.45
GRIN2C Q14957 1/20 0.45
GRIN3A Q8TCU5 1/20 0.45
DAO P14920 1/20 0.43
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
AHR P35869 1/20 0.41
MEN1 O00255 1/20 0.41
TTR P02766 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6364609 1.00 ALB (0.47) ALBKMT2AKDM4ESMN1; SMN2MCL1
SCHEMBL3204531 0.85 ALB (0.49) ALBKMT2AMCL1GRIN2DGRIN3B
SCHEMBL3204520 0.85 ALB (0.49) ALBKMT2AMCL1GRIN2DGRIN3B
SCHEMBL7135266 0.85 TTR (0.45) ALBKMT2AKDM4ESMN1; SMN2MCL1
SCHEMBL7135262 0.85 TTR (0.45) ALBKMT2AKDM4ESMN1; SMN2MCL1
SCHEMBL29247884 0.83 GRIN2D (0.51) ALBKMT2AKDM4ESMN1; SMN2MCL1
SCHEMBL7326492 0.83 MCL1 (0.54) ALBKMT2AMCL1GRIN2DGRIN3B
SCHEMBL7326486 0.83 MCL1 (0.54) ALBKMT2AMCL1GRIN2DGRIN3B
SCHEMBL9550204 0.83 KDM4E (0.45) KMT2AKDM4ESMN1; SMN2MCL1MEN1
SCHEMBL16756075 0.79 RAB9A (0.51) ALBKMT2AKDM4ESMN1; SMN2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070591-A1 Indole derivative KYOWA HAKKO KOGYO CO., LTD. (JP) 2005-03-31 US disclosed
EP-1464645-A1 INDOLE DERIVATIVE KYOWA HAKKO KOGYO CO., LTD. (JP) 2004-10-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070591-A1 Indole derivative TPH1, IDO1, RBX1 ALB 1442/4885KMT2A 1221/4885KDM4E 1406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.